IGF-I Treatment of Growth Hormone Insensitivity-Reference-Cited by-同舟云学术

IGF-I Treatment of Growth Hormone Insensitivity

Published:1999 Issue: Volume: Page:739-770
ISSN:
Container-title:The IGF System
language:
Short-container-title:

Author:

Rosenbloom Arlan L.

Publisher

Humana Press

Link

http://link.springer.com/content/pdf/10.1007/978-1-59259-712-3_31

Reference135 articles.

1. Laron Z, Blum W, Chatelain P, Ranke M, Rosenfeld R, Savage M, Underwood L. Classification of growth hormone insensitivity syndrome. J Pediatr 1993; 122: 241.

2. Laron Z, Pertzelan A, Mannheimer S. Genetic pituitary dwarfism with high serum concentration of growth hormone—a new inborn error of metabolism? Isr J Med Sci 1996; 2: 152–155.

3. Woods KA, Camacho-Hübner C, Savage MO, Clark AJL. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996; 335: 1363–1367.

4. Ayling RM, Ross R, Towner P, Von Laue S, Finidori J, Moutoussamy S, Buchanan CR, Clayton PE, Norman MR. A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nature Genet 1997; 16: 13–14.

5. lida K, Takahashi Y, Kaji H, Nose N, Ohmura Y, Abe H, Chihara K. Growth hormone (GH) insensitivity syndrome with high serum GH binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain. J Clin Endocrinol Metab 1998; 83: 531–537.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth Hormone Insensitivity;Pediatric Endocrinology;2018

2. Growth Hormone Insensitivity;Pediatric Endocrinology;2013

3. Recombinant Insulin-like Growth Factor I in Growth Therapy;Handbook of Growth and Growth Monitoring in Health and Disease;2011-10-25

4. Mecasermin (recombinant human insulin-like growth factor I);Advances in Therapy;2009-01

5. Advantages and disadvantages of GH/IGF-I combination treatment;Reviews in Endocrine and Metabolic Disorders;2008-07-06